Loading...
XSES
8K7
Market cap46mUSD
Dec 04, Last price  
0.10SGD
1D
0.00%
1Q
-6.73%
Jan 2017
2.11%
IPO
32.27%
Name

UG Healthcare Corporation Ltd

Chart & Performance

D1W1MN
XSES:8K7 chart
P/E
—
P/S
0.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.04%
Rev. gr., 5y
-0.02%
Revenues
144m
+25.06%
49,009,00055,740,00058,823,00065,239,00078,060,00091,712,000144,209,000338,401,000232,598,000101,133,000115,205,000144,074,000
Net income
-4m
L-37.35%
4,900,0003,164,0005,450,0002,444,0004,335,0002,507,00013,402,000118,765,00036,795,000-20,734,000-6,056,000-3,794,000
CFO
-5m
L-73.67%
1,927,0001,983,000-1,405,000-7,105,000-402,000-6,367,00010,989,00081,162,00053,950,000-39,142,000-18,156,000-4,780,000
Dividend
Nov 17, 20220.0032 SGD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. The company offers latex examination gloves that comprise single chlorinated and double chlorinated polymer coated gloves, as well as nitrile examination gloves. It also distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables, as well as shoe covers and other related products; and provides business and management consultancy services. The company's products are used in healthcare, food and beverage, industrial, high technology manufacturing, automotive, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Malaysia, Europe, North America, South America, Africa, and rest of Asia. The company was founded in 1989 and is based in Singapore.
URL
https://www.ughealthcarecorporation.com/
IPO date
Dec 08, 2014
Employees
1,076
Domiciled in
MY
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT